These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26512796)

  • 1. Oral Fluoroquinolones and the Risk of Uveitis.
    Sandhu HS; Brucker AJ; Ma L; VanderBeek BL
    JAMA Ophthalmol; 2016 Jan; 134(1):38-43. PubMed ID: 26512796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.
    Eftekhari K; Ghodasra DH; Haynes K; Chen J; Kempen JH; VanderBeek BL
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):745-52. PubMed ID: 24757075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study.
    Forooghian F; Maberley D; Albiani DA; Kirker AW; Merkur AB; Etminan M
    Ocul Immunol Inflamm; 2013 Oct; 21(5):390-3. PubMed ID: 23876164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study.
    Kapoor KG; Hodge DO; St Sauver JL; Barkmeier AJ
    Ophthalmology; 2014 Jun; 121(6):1269-73. PubMed ID: 24480710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Fluoroquinolone Use and Risk of Uveitis or Retinal Detachment.
    Brown JP; Wing K; Evans SJ; Leyrat C; Mansfield KE; Smeeth L; Wong AYS; Yorston D; Galwey NW; Douglas IJ
    JAMA Ophthalmol; 2024 Jul; 142(7):636-645. PubMed ID: 38814618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Oral Fluoroquinolone Use and Retinal Detachment.
    Raguideau F; Lemaitre M; Dray-Spira R; Zureik M
    JAMA Ophthalmol; 2016 Apr; 134(4):415-21. PubMed ID: 26967005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm.
    Newton ER; Akerman AW; Strassle PD; Kibbe MR
    JAMA Surg; 2021 Mar; 156(3):264-272. PubMed ID: 33404647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population.
    Seeger JD; West WA; Fife D; Noel GJ; Johnson LN; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):784-92. PubMed ID: 16456878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral uveitis associated with fluoroquinolone therapy.
    Hinkle DM; Dacey MS; Mandelcorn E; Kalyani P; Mauro J; Bates JH; Soukasian SH; Holland GN; Foster CS; Fraunfelder FT; Davis JL; Fraunfelder FW
    Cutan Ocul Toxicol; 2012 Jun; 31(2):111-6. PubMed ID: 21981449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.
    Inghammar M; Svanström H; Melbye M; Pasternak B; Hviid A
    BMJ; 2016 Feb; 352():i843. PubMed ID: 26920666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
    Ereshefsky BJ; Al-Hasan MN; Gokun Y; Martin CA
    J Chemother; 2017 Feb; 29(1):30-37. PubMed ID: 27376664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between oral fluoroquinolone use and retinal detachment.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA; 2013 Nov; 310(20):2184-90. PubMed ID: 24281462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.
    Novell MJ; Morreale CA
    Ann Pharmacother; 2010 May; 44(5):826-31. PubMed ID: 20354161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for uveitis with oral moxifloxacin: a comparative safety study.
    Eadie B; Etminan M; Mikelberg FS
    JAMA Ophthalmol; 2015 Jan; 133(1):81-4. PubMed ID: 25275293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
    Saad S; Mina N; Lee C; Afra K
    BMC Infect Dis; 2020 Oct; 20(1):785. PubMed ID: 33087051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis.
    Assimon MM; Pun PH; Wang LC; Al-Khatib SM; Brookhart MA; Weber DJ; Winkelmayer WC; Flythe JE
    JAMA Cardiol; 2022 Jan; 7(1):75-83. PubMed ID: 34668928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
    Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
    JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.
    Hsu SC; Chang SS; Lee MG; Lee SH; Tsai YW; Lin SC; Chen ST; Weng YC; Porta L; Wu JY; Lee CC
    PLoS One; 2017; 12(9):e0183813. PubMed ID: 28873440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between tendon ruptures and use of fluoroquinolone, and other oral antibiotics: a 10-year retrospective study of 1 million US senior Medicare beneficiaries.
    Baik S; Lau J; Huser V; McDonald CJ
    BMJ Open; 2020 Dec; 10(12):e034844. PubMed ID: 33371012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.
    Al-Hasan MN; Wilson JW; Lahr BD; Thomsen KM; Eckel-Passow JE; Vetter EA; Tleyjeh IM; Baddour LM
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1386-94. PubMed ID: 19164144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.